UnitedHealthcare, Humana and Aetna "have bastardized the system and they have ruined Medicare Advantage,” one Republican said.

A single insurer covered at least half of Medicare Advantage enrollees in 44% of counties in 2024, according to a KFF analysis.

The announcement follows the resignation of UVA Health CEO K. Craig Kent earlier this year.

Fortuna Health’s funding round comes at a perilous time for Medicaid.

Numerous Medicare Advantage insurers have sued regulators over changes to how star ratings are calculated.

Dexcom has recalled 19 models of its Dexcom G6, G7, One and One+ glucose monitoring receivers.

Setbacks in government health programs are hitting insurers, prompting Elevance, UnitedHealth, Centene and Molina to warn of worsening outlooks.

The Joint Commission has eliminated 714 requirements from its accreditation standards in an effort to streamline expectations and improve hospital compliance.

OpenEvidence gets $210M, $3.5B valuation from Google Ventures OpenEvidence, an artificial intelligence clinical decision support company, received $210 million in a Series B funding round.

Elevance Health is the latest insurer to downgrade its earnings guidance as troubles beset the sector.

PricewaterhouseCoopers’ Health Research Institute predicts expensive drugs, high rates of behavioral health claims and policy changes will boost spending.

The FDA has cleared medical devices from LivAssured, VivaQuant and other companies.